[ET Net News Agency, 10 June 2026] INNOGEN-B (02591) rose 11.2% to HK$9.47.
It hits an intra-day high of HK$9.58, and an intra-day low of HK$8.11, hitting a historical low. The total shares traded was 2.43 million, with a value of HK$21.3m. The active buy/sell ratio is 54:46, with net buying turnover of HK$1.73m. MORGAN STANLEY HK SEC accounts for greatest net responsive buying turnover of HK$437,468, with volume weighted average price of HK$8.325. CHINA INNOVATION MARKET SER accounts for greatest net responsive selling turnover of HK$341,254, with volume weighted average price of HK$8.555.
Basic Information| Nominal | 9.470 | % Chg | +11.15% |
| High | 9.580 | Low | 8.110 |
| Shares Tr | 2.43m | Turnover | 21.3m |
| 10-D SMA | 10.060 | %H.V | 98.347 |
| 20-D SMA | 11.456 | VWAP | 8.771 |
| 50-D SMA | 15.413 | RSI14 | 34.502 |
Status: Hitting a historical low, active buy/sell ratio is 54:46, with net buying turnover of HK$1.73m
Performance of stocks in the same sector or of relevance| Stock (Code) | Price (HK$) | Change (%) |
|---|
| INNOGEN-B (02591) | 9.47 | +11.15 |
| GENSCRIPT BIO (01548) | 11.49 | -0.52 |
| INNOVENT BIO (01801) | 74.20 | +1.44 |
| XTALPI (02228) | 6.87 | -1.58 |
| WUXI XDC (02268) | 44.58 | -2.75 |
| WUXI BIO (02269) | 29.24 | -2.34 |
| BEONE MEDICINES (06160) | 162.70 | +1.88 |
| SKB BIO (06990) | 404.20 | +4.34 |
| AKESO (09926) | 88.30 | -1.29 |
| REMEGEN (09995) | 70.40 | +1.66 |
(ed)
Nominal 
